NeutraKine® IFN Alpha 2A Monoclonal antibody
NeutraKine® IFN Alpha 2A Monoclonal Antibody for Neutralization,ELISA
Host / Isotype
Mouse / IgG1
Cat no : 69008-1-Ig
|Neutralization||Measured by its ability to neutralize Human IFN alpha 2A inhibition of growth on TF-1 cell line (human erythroleukemic cell line). The half neutralization dose (ND50) is typically 300-500 ng/mL in the presence of 100 ng/mL human INF alpha 2A.|
69008-1-Ig targets NeutraKine® IFN Alpha 2A in Neutralization,ELISA applications and shows reactivity with Human samples.
|Host / Isotype||Mouse / IgG1|
|Immunogen||human NeutraKine® IFN Alpha 2A protein HZ-1066|
|Full Name||interferon, alpha 2|
|Gene ID (NCBI)||3440|
|Purification Method||Protein G purification|
|Storage Buffer||Sterile PBS.|
|Reconstitution||This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.|
|Stability and Storage||Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.|
Interferon alpha 2 is a type 1 interferon. Interferon alpha 2 is secreted by virus-infected cells and inhibits other cells from further infection. Recombinant human interferon alpha 2 has been approved for therapeutic application in a range of human oncological and viral diseases. Three Interferon alpha 2 subvariants (2A, 2B, 2C) differ by only one or two amino acids at positions 23 and/or 34 of the mature protein (PMID: 25982860; 10672347; 1694761).
This antibody is used to Block/Neutralize Interferon alpha 2 protein.